All News

In his blog post on FDAVoice, Peter Lurie MD, MPH, associate FDA commissioner for public health strategy and analysis, announced the introduction of a draft form and a draft guideline that can be used by a physician to request access to an experimental drug or biological product that is still under development.

The House passed a bill on Tuesday to repeal the Affordable Care Act for the first time in the new Congress, but Democrats appeared to show more zeal in defending the law than Republicans did in trying to get rid of it.

Children, the poor, African Americans, and those living in rental housing remain at higher risk of exposure to secondhand smoke, which CDC says kills 41,000 nonsmoking adults and 400 infants a year.

The report, according to ASCO, delineates responsibilities of different stakeholders towards ensuring responsible data sharing of trial results.

The efficacy of the CDK4/6 inhibitor was demonstrated in 165 postmenopausal women with ER-positive, HER2-negative advanced breast cancer who had not received previous treatment for advanced disease.

The study, published in the Journal of Clinical Oncology concluded that the failure rate was low with observation but was decreased significantly with the addition of radiotherapy.

During remarks at the Office of the National Coordinator for Health Information Technology Annual Meeting 2015, HHS Secretary Sylvia M. Burwell announced a new funding opportunity to achieve interoperability.

The study identified distinct methylation patterns between the aggressive and benign forms of TNBC, which could provide an improved understanding of disease outcome.

The Agency for Healthcare Research and Quality (AHRQ) is a comparatively small part of the federal budget, but its research priorities for FY 2016 affect areas that consume huge sums.

A study published in the Journal of Thoracic Disease digs deep into understanding the assumptions in HEOR studies that evaluate the cost-effectiveness of personalized cancer treatments.

Amid President Barack Obama's planned Precision Medicine Initiative, the FDA is evaluating its regulatory approach to next-generation sequencing.

More than 400,000 Medicare beneficiaries who may have been confused or misinformed about the pharmacy details of their 2015 Aetna prescription drug plans have until the end of this month to find participating pharmacies or switch plans, according to CMS.

The report, sponsored by the Patient-Centered Primary Care Collaborative, reviewed 28 studies of PCMHs over a 1 year period; some of the studies found improved utilization resulted in an improvement in at least 1 cost metric.

Putting data in patient hands, the construction of an open API, and interoperability are big hopes for the future of health information technology (IT), according to panelists at the annual meeting of the Office of the national Coordinator for Health IT.

Panelists discuss ways to improve the focus on clinical utility in molecular diagnostics given challenges in the system and needs of patients.

The President's budget proposal for 2016 seeks to gain the ability to negotiate drug prices under Medicare Part D, which will definitely face resistance from the Republican-controlled Congress.

Health information technology (IT) can create greater healthcare disparities if all patient groups and their concerns aren't considered properly, panelists said on the first day of the annual meeting of the Office of the National Coordinator for Health IT.

The dual inhibitor tablet, a combination of an SGLT-2 inhibitor and a DPP-4 inhibitor, is expected to stimulate the pancreas to produce more insulin and stimulate the liver to produce less glucose, and also prevent glucose reabsorption.

Although estimates suggest more than 8% in the state suffer from diabetes, federal budge cuts have been partly responsible for the lack of funding.

Governor John Kasich changed eligibility rules to add 450,000 Ohioans to Medicaid last year. The budget he presents to the Legislature will be silent on reauthorizing those rules, but will call for changes to find savings elsewhere in the program.

The Obama administration's push to transform the way the US pays for healthcare is splitting the medical profession, as family doctors embrace changes that oncologists, neurologists and other specialists are concerned will cause turmoil.

Multiplexed genetic screening for EGFR and ALK gene rearrangements and subsequent biomarker-guided treatment is cost-effective compared with standard chemotherapy treatment without any molecular testing in the metastatic NSCLC setting in the United States, researchers report in The Journal of Thoracic Oncology.

With 3 I-O agents have already been approved for metastatic melanoma, 2 from BMS and 1 from Merck, the race for NSCLC has tightened with multiple ongoing clinical trials.

Companies including Google, Twitter, Yahoo and Advertising.com automatically obtain information from people visiting HealthCare.gov, according to analysis by congressional staffers.

Supporters of the Affordable Care Act worry that the tax-filing season will generate new anger as uninsured consumers learn that they must pay tax penalties.

Addressing primary medication nonadherence through a telephonic intervention from the physicians office was not any more successful than the usual phone calls from the pharmacy.

Insurers and state Medicaid agencies have been eager to strike a deal with pharmaceutical companies to secure discounts on pricey hepatitis C drugs.

New reports show that 2 big experiments run by the health law's innovation lab delivered mixed early results in enhancing primary care.

Although one of the central features of the Affordable Care Act was eliminating discrimination based on preexisting conditions, there is evidence insurers have found ways to dissuade high-cost patients from enrolling in their plans.

Lawmakers in Wyoming are working toward an agreement that would allow the state to accept hundreds of millions of federal dollars to expand the state's Medicaid program.